Technical Analysis for VRPX - Virpax Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.85 | -2.53% | -0.10 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical VRPX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | -2.53% | |
| Down 3 Days in a Row | Weakness | -2.53% | |
| Narrow Range Bar | Range Contraction | -3.27% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Possible NR7 | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| Down 2 % | 1 day ago |
| Down 1% | 1 day ago |
| 60 Minute Opening Range Breakout | 2 days ago |
Free Daily (Stock) Chart Reading
- Earnings date: ???
Virpax Pharmaceuticals, Inc. Description
Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; and NES100, an endogenous enkephalin intranasal spray for acute and chronic spray. The company develops drug delivery technologies, such as Topical metered-dose spray, Liposomal in Hydrogel encapsulation, and Enkephalin Intranasal spray. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pain Drugs Health Sciences Influenza Drug Delivery Euphoriants Pain Management Dosage Forms Analgesics Morphinans Opioids Bupivacaine Drug Delivery Systems Heroin Drug Delivery Technologies Post Traumatic Stress Disorder Morphine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.24 |
| 52 Week Low | 3.8 |
| Average Volume | 143,652 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 4.64 |
| 20-Day Moving Average | 4.08 |
| 10-Day Moving Average | 3.98 |
| Average True Range | 0.26 |
| ADX | 13.22 |
| +DI | 22.11 |
| -DI | 21.69 |
| Chandelier Exit (Long, 3 ATRs ) | 3.94 |
| Chandelier Exit (Short, 3 ATRs ) | 4.58 |
| Upper Bollinger Band | 4.35 |
| Lower Bollinger Band | 3.81 |
| Percent B (%b) | 0.07 |
| BandWidth | 13.25 |
| MACD Line | -0.22 |
| MACD Signal Line | -0.24 |
| MACD Histogram | 0.0192 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.15 | ||||
| Resistance 3 (R3) | 4.17 | 4.08 | 4.10 | ||
| Resistance 2 (R2) | 4.08 | 4.01 | 4.08 | 4.08 | |
| Resistance 1 (R1) | 3.97 | 3.96 | 3.93 | 3.95 | 4.07 |
| Pivot Point | 3.88 | 3.88 | 3.86 | 3.88 | 3.88 |
| Support 1 (S1) | 3.77 | 3.81 | 3.73 | 3.75 | 3.63 |
| Support 2 (S2) | 3.68 | 3.76 | 3.68 | 3.62 | |
| Support 3 (S3) | 3.57 | 3.68 | 3.60 | ||
| Support 4 (S4) | 3.55 |
